Need for Tracheostomy after Lung Transplant Predicts Decreased Mid- and Long-Term Survival.
Tracheostomy is an important adjunct for lung transplant patients requiring prolonged ventilation. We explored the effects of post-transplant tracheostomy on survival and bronchiolitis obliterans syndrome after lung transplant. A retrospective, single center analysis was performed on all lung transplant recipients during the Lung Allocation Score (LAS) era. Risk factors for post-transplant tracheostomy or death within 30 days were assessed. Kaplan-Meier estimates and Cox proportional hazards models were used to examine the association between tracheostomy within 30 days after transplant and survival at 1 and 3 years. 403 patients underwent single or bilateral lung transplant between May 2005 and February 2016 with complete data for 352 cases, and 35 patients (9.9%) underwent tracheostomy or died (N=10, 2.8%) within 30 days. In adjusted analyses, primary graft dysfunction grade 3 (PGD3) was associated with a composite endpoint of tracheostomy or death within 30 days (HR 3.11 (1.69,5.71), P-value<0.001). Tracheostomy within 30 days was associated with decreased survival at 1(HR 4.25(1.75, 10.35) P-value=0.001) and 3 years (HR 2.74(1.30, 5.76), P-value=0.008), as well as decreased bronchiolitis obliterans (BOS)-free survival at 1 (HR 1.87(1.02, 3.41) P-value=0.042) and 3 years (HR 2.15 (1.33, 3.5), P-value=0.002). Post-transplant tracheostomy is a marker for advanced lung allograft dysfunction with significant reduction in long-term overall and BOS-free survival.